Highlights and Quick Summary
- Income after Tax for the quarter ending September 30, 2023 was $-50.7 Million (a 19.64% increase compared to previous quarter)
- Year-over-year quarterly Income after Tax increased by 29.08%
- Annual Income after Tax for 2022 was $-122 Million (a -26.33% decrease from previous year)
- Annual Income after Tax for 2021 was $-165 Million (a 4749.47% increase from previous year)
- Twelve month Income after Tax ending September 30, 2023 was $-172 Million (a 14.2% increase compared to previous quarter)
- Twelve month trailing Income after Tax increased by 41.0% year-over-year
Trailing Income after Tax for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $-172 Million | $-150 Million | $-137 Million | $-122 Million |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income after Tax of Prime Medicine, Inc.
Most recent Income after Taxof PRME including historical data for past 10 years.Interactive Chart of Income after Tax of Prime Medicine, Inc.
Prime Medicine, Inc. Income after Tax for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-50.71 | $-42.39 | $-39.4 | – | – |
| 2022 | $-39.28 | $-29.35 | $-29.35 | $-23.84 | $-121.82 |
| 2021 | – | – | – | $-16.41 | $-165.37 |
| 2020 | – | – | – | – | $-3.41 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology